SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-054736
Filing Date
2023-11-08
Accepted
2023-11-08 18:13:26
Documents
2
Period of Report
2023-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2219
2 POA DOCUMENT poa.txt EX-24 2864
  Complete submission text file 0001209191-23-054736.txt   6463
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ANESIVA, INC. 650 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Viret Jean-Frederic (Reporting) CIK: 0001427569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38853 | Film No.: 231389493